RPGLIFE Stock Overview
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
RPG Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,210.10 |
| 52 Week High | ₹2,974.95 |
| 52 Week Low | ₹1,307.00 |
| Beta | 0.43 |
| 1 Month Change | 10.95% |
| 3 Month Change | 0.41% |
| 1 Year Change | 62.10% |
| 3 Year Change | 270.11% |
| 5 Year Change | 607.46% |
| Change since IPO | 4,822.27% |
Recent News & Updates
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings
Nov 15
RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
Oct 18Recent updates
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings
Nov 15RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
Oct 18Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%
Jul 25RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality
May 08RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00
Jul 11Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Sep 05Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now
Aug 24A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jun 14Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?
Feb 09Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?
Jan 13RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?
Dec 23
Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?
Nov 11Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Oct 21Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?
Sep 28What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?
Aug 31With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For
Aug 11What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E
Jul 28Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jul 10Shareholder Returns
| RPGLIFE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.7% | 0.8% | -4.2% |
| 1Y | 62.1% | 39.7% | 19.1% |
Return vs Industry: RPGLIFE exceeded the Indian Pharmaceuticals industry which returned 39.7% over the past year.
Return vs Market: RPGLIFE exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility
| RPGLIFE volatility | |
|---|---|
| RPGLIFE Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: RPGLIFE has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: RPGLIFE's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,270 | Yugal Kishor Sikri | www.rpglifesciences.com |
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India.
RPG Life Sciences Limited Fundamentals Summary
| RPGLIFE fundamental statistics | |
|---|---|
| Market cap | ₹36.55b |
| Earnings (TTM) | ₹706.60m |
| Revenue (TTM) | ₹6.18b |
51.7x
P/E Ratio5.9x
P/S RatioIs RPGLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RPGLIFE income statement (TTM) | |
|---|---|
| Revenue | ₹6.18b |
| Cost of Revenue | ₹2.04b |
| Gross Profit | ₹4.15b |
| Other Expenses | ₹3.44b |
| Earnings | ₹706.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 42.72 |
| Gross Margin | 67.08% |
| Net Profit Margin | 11.43% |
| Debt/Equity Ratio | 0% |
How did RPGLIFE perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 07:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
RPG Life Sciences Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kunal Dhamesha | Emkay Global Financial Services Ltd. |
| Kameswari V. S. Chavali | FirstCall Research |